Introduction
Adenoidectomy is a common procedure in pediatric populations, with approximately 130,000 performed each year in the United States with or without tonsillectomy. 1 While curettage (CU) has been a classic technique employed by otolaryngologists for decades, some contemporary techniques such as suction coagulation (SC) or electrocautery, microdebrider (MD), and Coblation (CO) adenoidectomy have become popular due to more precise visualization, ease of use, and reduced blood loss. 2, 3 Beginning in 2002, several studies have examined the efficacy of transitioning to electric-powered surgical techniques. Elluru et al found power-assisted methods to be faster and entail less blood loss than curettage. 2 These findings were corroborated by a 2009 meta-analysis conducted by Reed et al, which concluded that SC resulted in decreased intraoperative hemorrhage and operative time compared to CU adenoidectomy. 3 However, conflicting evidence about intraoperative blood loss exists. Stansifer et al found no significant difference in blood loss between CU and MD procedures but less bleeding with SC adenoidectomy. 4 More recently, several studies have investigated the potential complications of adenoid regrowth requiring revision surgery. The frequency of revision after primary adenoidectomy ranges from 0.5 to 2%. 1, 5, 6 A 5-year retrospective review found no significant difference in the incidence of revision adenoidectomy between SC-and MD-performed adenoidectomies. 6 This finding supports a 2012 Dearking et al review reporting no significant association between surgical technique used and the likelihood of having a revision adenoidectomy. 5 While few studies have examined adenoid regrowth after the use of different surgical instruments, we could only identify one published report describing the incidence of revision surgery associated with different types of surgical instruments. Grindle et al demonstrated an incidence of revision adenoidectomy of 1.3% after the use of monopolar 1 Our study aimed to answer a commonly asked question of parents while considering an adenoidectomy for their child: What is the chance of a second surgery? We sought to determine the incidence of revision surgery after adenoidectomy with the use of the different types of instruments for children under the age of 18 years over a 10-year period at our major tertiary children's center.
Patients and methods
A retrospective cohort study was performed at CHLA after obtaining approval from our Institutional Review Board (IRB). Medical records were searched from August 2004 to August 2014 for Current Procedural Terminology (CPT) codes designated for primary adenoidectomy in patients less than 12 years of age and greater than 12 years of age (42830/42831), adenoidectomy with tonsillectomy in patients less than 12 years of age and greater than 12 years of age (42820/42821), and revision adenoidectomy in patients less than 12 years of age and greater than 12 years of age (42835/42836). Patients who had revision adenoidectomies were also found using CPT codes for a second adenoidectomy or two occurrences of adenoidectomy codes for the same medical record. The electronic health records were then reviewed to collect data on sex, age, presence of Down syndrome, indication for surgery, concurrent procedure, technique used, presence of gastroesophageal reflux disease (GERD) at the time of both the initial and revision surgery, and any surgical complications.
Patients who had an initial surgery, or a primary adenoidectomy, at another institution were excluded from the study as the operative reports for those procedures were not available for review, nor would our IRB permit us to seek this documentation from patients or their guardians.
Indications for surgery were categorized as infectious (sinusitis, tonsillitis, adenoiditis), otologic (otitis-media-associated, eustachian tube dysfunction), nasal obstruction, or adenoid hypertrophy with sleep disordered breathing.
Patient characteristics and surgical information are described in percentages for categorical variables and means with standard deviations for continuous variables. Univariate analysis was performed using the Pearson chi-square test to analyze differences between the four groups across incidence of revision and patient characteristics such as age, sex, and GERD diagnosis.
For continuous variables such as age at initial and revision surgery, an analysis of variance (ANOVA) statistical test was performed. Statistical analysis was conducted using Stata software (StataCorp LLC; College Station, Texas), and significance of the tests was assessed at α = 0.05.
Results
During the 10-year study period, 5,659 adenoidectomies with or without tonsillectomies were performed using either an MD, CO, SC, or CU instrument. The MD technique was used in 212 primary adenoidectomies, the CO technique in 382, SC in 1,926, and CU in 3,139. A total of 51 revision surgeries were performed during the same period; 37 of these cases had a primary adenoidectomy that did not occur at CHLA were and excluded because we lacked documentation of the surgical technique used for that procedure.
Of the remaining 14 revision cases, 3 were initially performed with the MD technique, 3 with CO, 7 with SC, and 1 with CU (table). The incidence of revision surgery after initial adenoidectomy by the MD technique was 1.42%, 0.79% for CO, 0.36% for SC, and 0.03% for CU.
The cumulative incidence of revision adenoidectomy for initial surgeries performed at CHLA was 0.2% for the 10-year study period. A Pearson chi-square analysis showed a statistically significant difference between the surgical techniques (p < 0.0001) (table) .
When comparing the four groups, the mean age at initial surgery was 3.2 years (standard deviation [SD] ±1.8 years) for MD, 3.9 years (±1.9 years) for CO, 3.9 years (±1.8 years) for SC, and 6.2 years for CU. Mean age at revision surgery was 8.8 years (±0.8 years) for MD, 6.6 years (±1.7 years) for CO, 7.7 years (±2.5 years) for SC, and 7.21 years for CU (table) .
The differences in patient age at both first and secondary adenoidectomy between the surgical techniques were not statistically significant on ANOVA analysis (table) . The mean time between first and second adenoidectomies for the revision patient population for each technique was 5.6 years (±2.6) for MD, 2.7 years (±0.4) for CO, 3.9 years (±1.4) for SC, and 0.98 years for CU. ANOVA analysis did not reveal a statistically significant difference (p = 0.09) (table).
Of the 3 revision patients in the MD group, all were female. One of the three patients in the CO group and 3 of 7 in the SC group were female, as well as the lone revision patient in the CU group. Only 3 of the 14 included revision patients had a diagnosis of GERD at any point in their patient history. One each were in the MD, SC, and CU groups. Differences in sex or GERD were not found to be statistically significant on chi-square analysis (table) .
Indications for surgery and concurrent procedures performed for the four groups were also noted and assessed using univariate chi-square test analysis. The most common indication for initial adenoid surgery was adenoid hypertrophy contributing to upper airway obstruction (UAO) or sleep-disordered breathing (SDB). Adenoid hypertrophy causing UAO or SDB was an indication in 100% of the MD group (n = 3), 100%
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Otologic issues such as recurrent otitis media were an indication in 100% of the MD group (n = 3), 67% of the CO group (n = 2), 57% of the SC group (n = 4), and 0% of the CU group (p = 0.73). Chronic sinusitis was an indication for initial adenoidectomy in 1 SC patient while nasal obstruction was the sole indication for initial surgery for the 1 patient in the CU group. The most common indication for revision adenoidectomy was chronic otitis media and associated otologic issues.
Otologic concerns were listed as an indication in 100% of MD (n = 3), 100% of CO (n = 3), 86% of SC (n = 6), and 0% of CU revision surgeries (p = 0.80). OSA or SDB from adenoid hypertrophy was an indication for revision surgery in 67% of the MD group (n = 2), 100% of the CO group (n = 3), 57% of the SC group (n = 4), and 100% of the CU group (n = 1) (p = 0.88).
Concurrent procedures performed with initial adenoidectomy included tonsillectomy, bilateral myringotomy and tubes (BMT), bilateral endoscopic sinus surgery (ESS) with total ethmoidectomy revision (TER), and flexible laryngoscopy. Tonsillectomy was performed concurrently with initial adenoid surgery in 67% of the MD group (n = 2), 67% of the CO group (n = 2), 57% of the SC group (n = 4), and 0% of the CU group (p = 0.89).
BMT was performed during initial adenoid surgery in 100% of the MD group (n = 3), 67% of the CO group (n = 2), 57% of the SC group (n = 4), and 0% of the CU group (p = 0.73). Flexible laryngoscopy and ESS with TER were each performed concurrently once in the MD and SC group. During the revision adenoid surgeries, BMT was performed concurrently in 100% of the MD group (n = 3), 100% of the CO group (n = 3), 71% of the SC group (n = 5), and 0% of the CU group (p = 0.76).
The remaining 3 of the 14 revision surgery patients did not have a concurrent procedure performed.
Bilateral nasal endoscopy and flexible laryngoscopy each were performed concurrently with adenoidectomy, once for a SC and once for a CO patient, respectively. Concurrent procedures performed for each of the surgical techniques are shown in the figure.
Uncommon complications from adenoidectomy such as velopharyngeal insufficiency (VPI) and nasopharyngeal stenosis were not noted in any of the 14 revision patients. At CHLA, the Division of Plastic and Maxillofacial Surgery evaluates and treats VPI. No referrals to this Division were noted for any of the revision patients. Down syndrome, a known risk factor for adenoid hypertrophy, 7 was not indicated as a diagnosis for any of the revision patients.
Discussion
Recent publications have demonstrated an incidence of revision adenoidectomy between 0.8 and 1.5%. 1, 5, 6 The overall incidence of 0.2% demonstrated in our study is lower than those reported in the previously published studies including that of Grindle et al, which demonstrated a 1.3% overall incidence of revision for the same types of instruments as those we studied. 1 In their study, the mean age at the primary procedure was 2.8 years, which was lower than that in our group (3.9 years for the CO and SC group and as high as 6.2 years for the CU group).
A younger age at the time of the primary adenoidectomy (less than 4 years) has been proposed as posing an increased risk for revision surgery. 1, 5 If this is true, this may account for the reduced incidence of revision adenoidectomy demonstrated in our study.
The percentages of revision using MD and SC in our study (1.42% and 0.36%, respectively) were not statistically significantly different, which is consistent with the study by Sapthavee et al (0.84% and 1.5%, respectively). 6 The study by Grindle et al demonstrated the highest incidence with the use of SC (55 of 99 revision procedures), followed by MD (22 of 99 procedures), CU (21 of 99 procedures), and CO with only 1 of 99 procedures. 1 In that study, no statistical analysis was performed among the four different groups of surgical instruments. 1 Interestingly, in our study the incidence of 0.03% (1 revision adenoidectomy of 3,139 primary adenoidectomies) for revision surgery after an adenoidectomy performed with a CU when compared to SC, MD, and CO was statistically significant on univariate analysis. This is a unique finding of our study and differs from the study by Grindle et al, which demonstrated only 1 revision procedure after the use of CO. 1 We cannot further examine this difference between these studies since our study documented that CU was used in 3,139 primary procedures but Grindle et al did not specify the number of primary procedures performed with CO. 1 The statistically significant difference with the use of CU is especially striking given that several reports have demonstrated that the use of CU may leave adenoid tissue remaining, especially in the peritubal areas. 1, 5 At our institution, CU is used under constant direct visualization with a mirror as compared to the use of digital palpation, which has been described at other institutions and may account for a reduced incidence of regrowth necessitating a revision procedure.
The routine use of a St. Clair-Thompson adenoid forceps after CU to ensure a more complete removal of tissue in the peritubal areas and choanae may be another contributing factor to the uniquely low incidence of revision seen after the use of CU in our study. Finally, the technical proficiency of the surgeon may be a consideration, as well as the fact that the two most senior surgeons used CU most often while the more recently trained attending surgeons primarily used SC, MD, and CO.
Without question, the presence of a resident surgeon demonstrated no effect as all cases were directly supervised by an attending surgeon; for all cases, an attending surgeon examined the nasopharynx and removed additional tissue if necessary before the end of the procedure.
GERD has been associated with adenoid hypertrophy and an increased risk for revision surgery. 5, 7 Hypotheses for the stimulus for regrowth of adenoid tissue include irritation of the respiratory mucosa from acid, leading to edema and increased secretions. 7 GERD diagnosis at any point in the patient's history has been identified as having a significant correlation with revision surgery. 5 As there were only 3 revision patients having any history of GERD in this study, no statistical correlations could be drawn.
The most frequent indication for initial adenoidectomy was UAO or SDB due to adenoid hypertrophy, which is consistent with the study by Sapthavee et al, which found that there was a statistically significant trend toward more revision patients having their initial surgery for UAO/SDB as compared to those www.entjournal.com E9
The incidence of revision adenoidecTomy: a comparison of four surgical Techniques over a 10-year period patients who had the primary adenoidectomy for otologic concerns, nasal obstruction, or infection. 6 A concurrent BMT with a revision adenoidectomy was a common occurrence in our study and is consistent with previously published literature showing a strong link between ear-related indications and revision surgery risk. 5 Eleven of the 14 revision patients had a concurrent BMT. It is more likely than not that the surgeon performed a revision adenoidectomy to improve eustachian tube function with the primary goal of reducing the risk of another set of ear tubes in the future, rather than to improve nasal obstruction due to adenoid hypertrophy resulting from adenoid regrowth. This is consistent with the study by Sapthavee et al, which noted the confounding nature of concurrent BMT and tonsillectomy procedures and concluded that it was uncertain whether the adenoid regrowth warranted a revision procedure due to its size alone. 6 It appears that the primary indication for revision adenoidectomy is to improve eustachian tube dysfunction rather than nasal obstruction.
More recent studies have recognized that cost is an important consideration in the choice of surgical instruments. To be complete, this would include an analysis of both direct costs and indirect costs. Given the retrospective nature of this study, such an analysis is beyond its scope. However, we can offer a comparison of the direct costs with the previously published literature.
At CHLA, the direct costs for MD, CO, and SC are $168, $262, and $5.79, respectively. This compares favorably with the Sapthavee et al study, which noted that the direct costs of MD and SC at the Lurie Children's Hospital in Chicago were $200 and $6.11, respectively, with two of the surgeons citing cost as their reason for using SC over MD. 6 At CHLA, the cost of CU is $123, and a St. Clair-Thompson adenoid forceps is $235.88. However, unlike the MD, CO, and SC handpieces, these instruments are used in multiple cases, which reduces their cost. Both the CU and the St. Clair-Thompson forceps have additional but immaterial costs, such as $7 for sharpening, which occurs about once every quarter.
While the methodology used in this study was the same as that of previously published studies and our study's period of 10 years compares favorably, a limiting factor is its small sample size. Over a 10-year period, we collected 5,659 adenoidectomies with or without tonsillectomy in children under 18 years. We had 51 revision adenoidectomies, which was further reduced to 14 as the primary adenoidectomy was performed at an outside institution in 37 cases, which were excluded. In the study by Grindle et al, 23,612 primary adenoidectomies were identified over a 5-year period in children under 12 years, with 304 revision cases, although only 99 were examined in more detail as they had the operative reports for these cases only. 1 Our group had only 6 surgeons while the Grindle et al group included 15, which may account for a smaller number of procedures identified in our study. 1 In the study by Dearking et al, 8,245 primary adenoidectomies were identified over a 29-year period in children under 18 years, with 163 revision cases. 5 In the study by Sapthavee et al, 7,399 primary adenoidectomies were identified over a 4-year period in children under 18 years with 120 revision cases, although only 85 were examined in more detail. 6 Additional limitations of this study are a consequence of its retrospective nature. Some individuals who had their primary surgery at CHLA might have had a revision surgery some time later at another institution, or the CHLA medical records might not have been accurate or might have been misread. Any of these occurrences could result in an underestimation of the incidence of revision surgery.
This study is also limited in that there was no comparison of adenoid size for any procedure. This was not possible given the fact that the surgeons either did not record a specific adenoid size or did not use a uniform grading system.
Finally, this study is further limited as it did not include any assessment of an allergic component in each patient. This was not possible since the medical records were not uniform in the amount of information on the presence, absence, or severity of any allergic conditions.
Conclusion
Regrowth of adenoid tissue requiring revision surgery occurs very infrequently regardless of the instrument used for the primary procedure, and the most common indication for revision adenoidectomy is to improve eustachian tube dysfunction rather than nasal obstruction due to adenoid hypertrophy.
